$SEM Investigation Notice: BFA Law is Investigating the Select Medical Board for Breaching its Duties to Shareholders after $16.50 Acquisition Announced

NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/select-medical-merger-lawsuit Why is Select Medical being Investigated?

GlobeNewsWire • Jun 17, 2026

SEM Shareholder News: Select Medical Investors may have Rights in Investigation over $16.50 per share Acquisition – Current Shareholders Urged to Contact BFA Law

NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/select-medical-merger-lawsuit Why is Select Medical being Investigated?

GlobeNewsWire • Jun 15, 2026

$SEM Stock Drop Reminder: Select Medical Announces $16.50 per share Acquisition – BFA Law's Investigation into the Board is Ongoing

NEW YORK, June 12, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/select-medical-merger-lawsuit Why is Select Medical being Investigated?

GlobeNewsWire • Jun 12, 2026

Select Medical Investigation: Select Medical (SEM) Board Investigated after Announcing $16.50 per share Acquisition – Contact BFA Law if You Hold Shares

NEW YORK, June 10, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/select-medical-merger-lawsuit Why is Select Medical being Investigated?

GlobeNewsWire • Jun 10, 2026

Johnson Fistel Investigates Potential Board Fiduciary Duty Breaches in the Select Medical Take-Private Transaction

SAN DIEGO, June 10, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of Select Medical Holdings Corporation (NYSE: SEM) breached their fiduciary duties in connection with the proposed sale of the company to a consortium led by Robert A. Ortenzio, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe.

GlobeNewsWire • Jun 10, 2026

Attention Select Medical Investors: Kaskela Law LLC is Investigating the Proposed $16.50 Per Share Shareholder Buyout and Encourages Investors to Contact the Firm to Protect Their Investment

NEWTOWN SQUARE, Pa., June 09, 2026 (GLOBE NEWSWIRE) -- Shareholder protection law firm Kaskela Law is investigating the recently announced buyout of Select Medical Holdings Corp. (NYSE: SEM) (“Select Medical”) shareholders to determine whether the transaction as structured is fair and provides investors with a sufficient premium for their SEM shares.

GlobeNewsWire • Jun 9, 2026

$SEM Securities Notice: BFA Law Notifies Select Medical Shareholders the Pending Investigation into the $16.50 per share Acquisition

NEW YORK, June 08, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/select-medical-merger-lawsuit Why is Select Medical being Investigated?

GlobeNewsWire • Jun 8, 2026

$SEM Stock Notification: Current Shareholder of Select Medical? Contact BFA Law about its Ongoing Investigation into the Board Over $16.50 per share Acquisition

NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/select-medical-merger-lawsuit Why is Select Medical being Investigated?

GlobeNewsWire • Jun 5, 2026

SEM Alert: BFA Law Reminds Select Medical Shareholders of its Pending Investigation into the Board after $16.50 per share Acquisition is Announced

NEW YORK--(BUSINESS WIRE)---- $SEM #BFA--BFA Law Reminds Select Medical Shareholders of its Pending Investigation into the Board after $16.50 per share Acquisition is Announced.

Business Wire • Jun 4, 2026

Kaskela Law LLC Announces Investigation into Fairness of $16.50 Per Share Select Medical Holdings (SEM) Stockholder Buyout; Affected Investors are Encouraged to Contact the Firm to Protect Their Investment and Legal Rights

NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Shareholder litigation law firm Kaskela Law is investigating the fairness of the recently announced buyout of Select Medical Holdings Corp. (NYSE: SEM) (“Select Medical”) shareholders to determine whether the transaction as structured provides investors with a sufficient price for their shares. Click here to register for additional information about this investigation: https://kaskelalaw.com/case/select-medical/ On March 2, 2026, Select Medical announced th.

Business Wire • Jun 4, 2026